Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Up-regulated lung cancer gene clone 10 protein" is a human protein encoded by the gene URLC10. It has been identified as being upregulated in lung cancer, particularly in non-small cell lung carcinoma (NSCLC). Its overexpression may be associated with tumor progression or poor prognosis, although detailed functional studies are limited. It could serve as a diagnostic marker for early detection of NSCLC or a prognostic indicator if further studies confirm correlation with disease outcome, and potentially as an immunotherapeutic target if found essential for tumor survival or immune evasion. More research is needed to clarify its precise biological function and clinical utility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Up-regulated lung cancer gene clone 10 protein.